Benjamin Y. Lu, MD, PhD
Thoracic Oncology
Biography
Benjamin Y. Lu, MD, PhD, is a medical oncologist specializing in thoracic oncology, focusing on the treatment of lung and skin cancers, as well as primary and metastatic brain tumors. Dr. Lu is dedicated to advancing immune therapies, which harness the body's own immune system to combat cancer, particularly in brain tumors. He employs various innovative approaches to improve patient outcomes.
As an instructor in medicine at Yale School of Medicine, Dr. Lu conducts research on immune-based treatments for tumors that originate in the brain or spread there. He studies how certain white blood cells, called T cells, respond to cancer in order to develop new therapeutic strategies.
Dr. Lu received his medical training from New York University School of Medicine and completed his residency in internal medicine at Yale New Haven Hospital. He further specialized with a fellowship in medical oncology at Yale Cancer Center. His contributions to the field have been recognized by prestigious awards such as the Young Investigator Award from the Conquer Cancer Foundation and the Emerging Generation Award from the American Society of Clinical Investigation.
Titles
- Instructor in Medicine (Medical Oncology)
Education & Training
- PhDYale University, Investigative Medicine (2024)
- Postdoctoral FellowYale School of Medicine (2023)
- Chief FellowYale Cancer Center (2022)
- FellowshipYale Cancer Center (2022)
- ResidencyYale New Haven Hospital (2019)
- InternshipMassachusetts General Hospital (2016)
- MDNew York University (2015)
Additional Information
Honors & Recognitions
- Emerging Generation Award: American Society of Clinical Investigation (ASCI) (2025)
- K12 Paul Calabresi Career Development Award for Clinical Oncology: National Cancer Institute (2023)
- T32 Ruth L. Kirschstein National Research Service Award: National Cancer Institute (2021)
- Young Investigator Award: Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) (2021)
- Lucien Rubinstein Award: American Brain Tumor Association (ABTA) (2012)
Professional Service
- Janeway Society (2024 - Present): Member
Publications
- Lu B, Lucca L, Lewis W, Wang J, Nogueira C, Heer S, Rayon-Estrada V, Axisa P, Reeves S, Buitrago-Pocasangre N, Pham G, Kojima M, Wei W, Aizenbud L, Bacchiocchi A, Zhang L, Walewski J, Chiang V, Olino K, Clune J, Halaban R, Kluger Y, Coyle A, Kisielow J, Obermair F, Kluger H, Hafler D. Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma. Nature Immunology 2024, 26: 82-91. PMID: 39609626, DOI: 10.1038/s41590-024-02023-4.
- Schoenfeld D, Djureinovic D, Su D, Zhang L, Lu B, Kamga L, Mann J, Huck J, Hurwitz M, Braun D, Jilaveanu L, Ring A, Kluger H. Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinoma. JCI Insight 2024, 10: e184545. PMID: 39561007, PMCID: PMC11721305, DOI: 10.1172/jci.insight.184545.
- Vilariño N, Lopez De Rodas M, Ranjan K, Costantini A, Villalba M, Lu B, Kravitz C, Nadal E, Goldberg S, Nguyen D, Schalper K. HLA class-I antigen presentation machinery (APM) alterations mediate immune evasion in lung cancer brain metastases. Journal Of Clinical Oncology 2024, 42: e14014-e14014. DOI: 10.1200/jco.2024.42.16_suppl.e14014.
- Butt A, Christian J, Kress A, Lu B, Hurwitz M, Goldberg S, Podoltsev N, Gilkes L, Lee A. Providing 0.1 Full-Time Equivalent (FTE) Support to Fellowship Core Faculty Improves Faculty Involvement in Fellowship Education and Recruitment. Journal Of Cancer Education 2024, 39: 325-334. PMID: 38430454, DOI: 10.1007/s13187-024-02414-z.
- Pucciarelli D, Lu B, Zlobec I, DiStasio M. Beyond the Lab and Into the Hospital: An Outlook on the Clinical Utility of Spatial Omics Technologies. GEN Biotechnology 2023, 2: 360-371. DOI: 10.1089/genbio.2023.0030.
- Lu B, Goldberg S. Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy? Journal Of Clinical Oncology 2023, 41: 4462-4464. PMID: 37603819, DOI: 10.1200/jco.23.01323.
- Lu B, Lucca L, DiStasio M, Liu Y, Pham G, Buitrago-Pocasangre N, Arnal-Estape A, Moliterno J, Chiang V, Omuro A, Hafler D. BSBM-18 SINGLE-CELL PROFILING TUMOR-INFILTRATING IMMUNE CELLS REVEALS CXCL13+ FOLLICULAR HELPER-LIKE CD4+ T CELLS IN HUMAN BRAIN TUMORS. Neuro-Oncology Advances 2023, 5: iii4-iii4. PMCID: PMC10402449, DOI: 10.1093/noajnl/vdad070.014.
- Vilarino N, de Rodas M, Lu B, Goldberg S, Schalper K. BSBM-16 HLA CLASS-I ANTIGEN PRESENTATION MACHINERY AND IFN-γ PATHWAY ALTERATIONS IN LUNG CANCER BRAIN METASTASES. Neuro-Oncology Advances 2023, 5: iii4-iii4. PMCID: PMC10402438, DOI: 10.1093/noajnl/vdad070.012.
- Pauken KE, Lagattuta KA, Lu BY, Lucca LE, Daud AI, Hafler DA, Kluger HM, Raychaudhuri S, Sharpe AH. TCR-sequencing in cancer and autoimmunity: barcodes and beyond. Trends In Immunology 2022, 43: 180-194. PMID: 35090787, PMCID: PMC8882139, DOI: 10.1016/j.it.2022.01.002.
- Kaulen LD, Lu BY, Goldberg SB, Baehring JM, Chapter 15 - Neurological complications of lung cancer, Editor(s): Herbert B. Newton, Mark G. Malkin, Neurological Complications of Systemic Cancer and Antineoplastic Therapy (Second Edition), Academic Press, 2022, Pages 243-276, DOI: 10.1016/b978-0-12-821976-8.00027-x
- Lu BY, Gupta R, Aguirre-Ducler A, Gianino N, Wyatt H, Ribeiro M, Chiang VL, Contessa JN, Adeniran AJ, Jilaveanu LB, Kluger HM, Schalper KA, Goldberg SB. Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases. Journal For ImmunoTherapy Of Cancer 2021, 9: e002684. PMID: 34670827, PMCID: PMC8529973, DOI: 10.1136/jitc-2021-002684.
- Lu BY, Isitan C, Mahajan A, Chiang V, Huttner A, Mitzner JR, Wesley SF, Goldberg SB. Intracranial Complications From Immune Checkpoint Therapy in a Patient With NSCLC and Multiple Sclerosis: Case Report. JTO Clinical And Research Reports 2021, 2: 100183. PMID: 34590030, PMCID: PMC8474265, DOI: 10.1016/j.jtocrr.2021.100183.
- Lucca LE, Axisa PP, Lu B, Harnett B, Jessel S, Zhang L, Raddassi K, Zhang L, Olino K, Clune J, Singer M, Kluger HM, Hafler DA. Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells. Journal Of Experimental Medicine 2021, 218: e20200921. PMID: 33651881, PMCID: PMC7933991, DOI: 10.1084/jem.20200921.
- Tran TT, Rane CK, Zito CR, Weiss SA, Jessel S, Lucca L, Lu BY, Oria VO, Adeniran A, Chiang VL, Omay SB, Hafler DA, Kluger HM, Jilaveanu LB. Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells. Cancers 2021, 13: 1049. PMID: 33801444, PMCID: PMC7958624, DOI: 10.3390/cancers13051049.
- Eguren-Santamaria I, Sanmamed MF, Goldberg SB, Kluger HM, Idoate MA, Lu B, Corral J, Schalper KA, Herbst RS, Gil-Bazo I. PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice. Clinical Cancer Research 2020, 26: 4186-4197. PMID: 32354698, DOI: 10.1158/1078-0432.ccr-20-0798.
- Lu B, Gupta R, Stewart T, Kluger H, Jilaveanu L, Schalper K, Goldberg S. Functional profile and clinical significance of major tumor infiltrating lymphocyte subsets in lung cancer-associated brain metastases. Journal Of Clinical Oncology 2019, 37: 2066-2066. DOI: 10.1200/jco.2019.37.15_suppl.2066.
- Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, McLendon RE, Lipp ES, Gururangan S, Grossbach A, French P, Kros JM, van Veelen MC, Rao AAN, Giannini C, Leary S, Jung S, Faria CC, Mora J, Schüller U, Alonso MM, Chan JA, Klekner A, Chambless LB, Hwang EI, Massimino M, Eberhart CG, Karajannis MA, Lu B, Liau LM, Zollo M, Ferrucci V, Carlotti C, Tirapelli DPC, Tabori U, Bouffet E, Ryzhova M, Ellison DW, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Pfister SM, Taylor MD, Aldape K, Pajtler KW, Kool M, Ramaswamy V. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathologica 2018, 136: 227-237. PMID: 30019219, PMCID: PMC6373486, DOI: 10.1007/s00401-018-1888-x.
- Lu B, Gupta R, Ribeiro M, Stewart T, Chiang V, Contessa J, Adeniran A, Kluger H, Jilaveanu L, Schalper K, Goldberg S. PD-L1 expression and tumor-infiltrating lymphocytes in lung cancer brain metastases. Journal Of Clinical Oncology 2018, 36: e24116-e24116. DOI: 10.1200/jco.2018.36.15_suppl.e24116.
- Madhusoodhan P, Lu B, Chen J, Jones C, Meyer J, Roman E, Nardi M, Carroll W, Bhatla T. Splice site mutation in factor X gene manifesting as severe intracranial haemorrhage in neonatal period with a challenging treatment course. Haemophilia 2016, 23: e138-e140. PMID: 27995737, DOI: 10.1111/hae.13138.
- Lu B, Kojima L, Huang M, Friedmann A, Ferry J, Weinstein H. Facial manifestations of Epstein–Barr virus‐related lymphoproliferative disease in childhood acute lymphoblastic leukemia in remission: Two atypical presentations. Pediatric Blood & Cancer 2016, 63: 2042-2045. PMID: 27392033, DOI: 10.1002/pbc.26102.
- Lu B, Thanawala S, Zochowski K, Burke M, Carroll W, Bhatla T. Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples. Leukemia & Lymphoma 2016, 57: 1938-1941. PMID: 26726842, DOI: 10.3109/10428194.2015.1110747.
- Bhatla T, Dandekar S, Lu B, Wang J, Han E, Bitterman D, Jones C, Evensen N, Magid M, Meyer J, Carroll W. Genomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric Patient. Journal Of Pediatric Hematology/Oncology 2016, 38: e21-e25. PMID: 26558807, PMCID: PMC4681625, DOI: 10.1097/mph.0000000000000463.
- Lu B, Kudlowitz D, Gardner L. Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test. Journal Of Blood Medicine 2015, 6: 277-283. PMID: 26640392, PMCID: PMC4657791, DOI: 10.2147/jbm.s90179.
- Henslee A, Yoon D, Lu B, Yu J, Arango A, Marruffo L, Seng L, Anver T, Ather H, Nair M, Piper S, Demian N, Wong M, Kasper F, Mikos A. Characterization of an injectable, degradable polymer for mechanical stabilization of mandibular fractures. Journal Of Biomedical Materials Research Part B Applied Biomaterials 2014, 103: 529-538. PMID: 24934595, DOI: 10.1002/jbm.b.33216.
- Haynes M, Lu B, Winkel A. Ovarian Vein Thrombophlebitis Related to Large Uterine Myoma. Obstetrics And Gynecology 2014, 123: 450-453. PMID: 24413242, DOI: 10.1097/aog.0000000000000091.
- Neumann O, Feronti C, Neumann A, Dong A, Schell K, Lu B, Kim E, Quinn M, Thompson S, Grady N, Nordlander P, Oden M, Halas N. Compact solar autoclave based on steam generation using broadband light-harvesting nanoparticles. Proceedings Of The National Academy Of Sciences Of The United States Of America 2013, 110: 11677-11681. PMID: 23836642, PMCID: PMC3718182, DOI: 10.1073/pnas.1310131110.
- Spiegel G, Dinh C, Gutierrez A, Lukomnik J, Lu B, Shah K, Slough T, Yeh P, Mirabal Y, Gray L, Marton S, Adler M, Schutze G, Wickham H, Oden M, Richards-Kortum R. Design, Evaluation, and Dissemination of a Plastic Syringe Clip to Improve Dosing Accuracy of Liquid Medications. Annals Of Biomedical Engineering 2013, 41: 1860-1868. PMID: 23471817, DOI: 10.1007/s10439-013-0780-z.
- Hároz E, Duque J, Lu B, Nikolaev P, Arepalli S, Hauge R, Doorn S, Kono J. Unique Origin of Colors of Armchair Carbon Nanotubes. Journal Of The American Chemical Society 2012, 134: 4461-4464. PMID: 22239488, DOI: 10.1021/ja209333m.
- Hároz E, Rice W, Lu B, Ghosh S, Hauge R, Weisman R, Doorn S, Kono J. Enrichment of Armchair Carbon Nanotubes via Density Gradient Ultracentrifugation: Raman Spectroscopy Evidence. ACS Nano 2010, 4: 1955-1962. PMID: 20302343, DOI: 10.1021/nn901908n.
- Murakami Y, Lu B, Kazaoui S, Minami N, Okubo T, Maruyama S. Photoluminescence sidebands of carbon nanotubes below the bright singlet excitonic levels. Physical Review B 2009, 79: 195407. DOI: 10.1103/physrevb.79.195407.
- Natoli R, Responte D, Lu B, Athanasiou K. Effects of multiple chondroitinase ABC applications on tissue engineered articular cartilage. Journal Of Orthopaedic Research® 2009, 27: 949-956. PMID: 19123232, PMCID: PMC2819396, DOI: 10.1002/jor.20821.
Departments and Programs
Biography
Benjamin Y. Lu, MD, PhD, is a medical oncologist specializing in thoracic oncology, focusing on the treatment of lung and skin cancers, as well as primary and metastatic brain tumors. Dr. Lu is dedicated to advancing immune therapies, which harness the body's own immune system to combat cancer, particularly in brain tumors. He employs various innovative approaches to improve patient outcomes.
As an instructor in medicine at Yale School of Medicine, Dr. Lu conducts research on immune-based treatments for tumors that originate in the brain or spread there. He studies how certain white blood cells, called T cells, respond to cancer in order to develop new therapeutic strategies.
Dr. Lu received his medical training from New York University School of Medicine and completed his residency in internal medicine at Yale New Haven Hospital. He further specialized with a fellowship in medical oncology at Yale Cancer Center. His contributions to the field have been recognized by prestigious awards such as the Young Investigator Award from the Conquer Cancer Foundation and the Emerging Generation Award from the American Society of Clinical Investigation.
Titles
- Instructor in Medicine (Medical Oncology)
Education & Training
- PhDYale University, Investigative Medicine (2024)
- Postdoctoral FellowYale School of Medicine (2023)
- Chief FellowYale Cancer Center (2022)
- FellowshipYale Cancer Center (2022)
- ResidencyYale New Haven Hospital (2019)
- InternshipMassachusetts General Hospital (2016)
- MDNew York University (2015)
Additional Information
Honors & Recognitions
- Emerging Generation Award: American Society of Clinical Investigation (ASCI) (2025)
- K12 Paul Calabresi Career Development Award for Clinical Oncology: National Cancer Institute (2023)
- T32 Ruth L. Kirschstein National Research Service Award: National Cancer Institute (2021)
- Young Investigator Award: Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) (2021)
- Lucien Rubinstein Award: American Brain Tumor Association (ABTA) (2012)
Professional Service
- Janeway Society (2024 - Present): Member
Publications
- Lu B, Lucca L, Lewis W, Wang J, Nogueira C, Heer S, Rayon-Estrada V, Axisa P, Reeves S, Buitrago-Pocasangre N, Pham G, Kojima M, Wei W, Aizenbud L, Bacchiocchi A, Zhang L, Walewski J, Chiang V, Olino K, Clune J, Halaban R, Kluger Y, Coyle A, Kisielow J, Obermair F, Kluger H, Hafler D. Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma. Nature Immunology 2024, 26: 82-91. PMID: 39609626, DOI: 10.1038/s41590-024-02023-4.
- Schoenfeld D, Djureinovic D, Su D, Zhang L, Lu B, Kamga L, Mann J, Huck J, Hurwitz M, Braun D, Jilaveanu L, Ring A, Kluger H. Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinoma. JCI Insight 2024, 10: e184545. PMID: 39561007, PMCID: PMC11721305, DOI: 10.1172/jci.insight.184545.
- Vilariño N, Lopez De Rodas M, Ranjan K, Costantini A, Villalba M, Lu B, Kravitz C, Nadal E, Goldberg S, Nguyen D, Schalper K. HLA class-I antigen presentation machinery (APM) alterations mediate immune evasion in lung cancer brain metastases. Journal Of Clinical Oncology 2024, 42: e14014-e14014. DOI: 10.1200/jco.2024.42.16_suppl.e14014.
- Butt A, Christian J, Kress A, Lu B, Hurwitz M, Goldberg S, Podoltsev N, Gilkes L, Lee A. Providing 0.1 Full-Time Equivalent (FTE) Support to Fellowship Core Faculty Improves Faculty Involvement in Fellowship Education and Recruitment. Journal Of Cancer Education 2024, 39: 325-334. PMID: 38430454, DOI: 10.1007/s13187-024-02414-z.
- Pucciarelli D, Lu B, Zlobec I, DiStasio M. Beyond the Lab and Into the Hospital: An Outlook on the Clinical Utility of Spatial Omics Technologies. GEN Biotechnology 2023, 2: 360-371. DOI: 10.1089/genbio.2023.0030.
- Lu B, Goldberg S. Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy? Journal Of Clinical Oncology 2023, 41: 4462-4464. PMID: 37603819, DOI: 10.1200/jco.23.01323.
- Lu B, Lucca L, DiStasio M, Liu Y, Pham G, Buitrago-Pocasangre N, Arnal-Estape A, Moliterno J, Chiang V, Omuro A, Hafler D. BSBM-18 SINGLE-CELL PROFILING TUMOR-INFILTRATING IMMUNE CELLS REVEALS CXCL13+ FOLLICULAR HELPER-LIKE CD4+ T CELLS IN HUMAN BRAIN TUMORS. Neuro-Oncology Advances 2023, 5: iii4-iii4. PMCID: PMC10402449, DOI: 10.1093/noajnl/vdad070.014.
- Vilarino N, de Rodas M, Lu B, Goldberg S, Schalper K. BSBM-16 HLA CLASS-I ANTIGEN PRESENTATION MACHINERY AND IFN-γ PATHWAY ALTERATIONS IN LUNG CANCER BRAIN METASTASES. Neuro-Oncology Advances 2023, 5: iii4-iii4. PMCID: PMC10402438, DOI: 10.1093/noajnl/vdad070.012.
- Pauken KE, Lagattuta KA, Lu BY, Lucca LE, Daud AI, Hafler DA, Kluger HM, Raychaudhuri S, Sharpe AH. TCR-sequencing in cancer and autoimmunity: barcodes and beyond. Trends In Immunology 2022, 43: 180-194. PMID: 35090787, PMCID: PMC8882139, DOI: 10.1016/j.it.2022.01.002.
- Kaulen LD, Lu BY, Goldberg SB, Baehring JM, Chapter 15 - Neurological complications of lung cancer, Editor(s): Herbert B. Newton, Mark G. Malkin, Neurological Complications of Systemic Cancer and Antineoplastic Therapy (Second Edition), Academic Press, 2022, Pages 243-276, DOI: 10.1016/b978-0-12-821976-8.00027-x
- Lu BY, Gupta R, Aguirre-Ducler A, Gianino N, Wyatt H, Ribeiro M, Chiang VL, Contessa JN, Adeniran AJ, Jilaveanu LB, Kluger HM, Schalper KA, Goldberg SB. Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases. Journal For ImmunoTherapy Of Cancer 2021, 9: e002684. PMID: 34670827, PMCID: PMC8529973, DOI: 10.1136/jitc-2021-002684.
- Lu BY, Isitan C, Mahajan A, Chiang V, Huttner A, Mitzner JR, Wesley SF, Goldberg SB. Intracranial Complications From Immune Checkpoint Therapy in a Patient With NSCLC and Multiple Sclerosis: Case Report. JTO Clinical And Research Reports 2021, 2: 100183. PMID: 34590030, PMCID: PMC8474265, DOI: 10.1016/j.jtocrr.2021.100183.
- Lucca LE, Axisa PP, Lu B, Harnett B, Jessel S, Zhang L, Raddassi K, Zhang L, Olino K, Clune J, Singer M, Kluger HM, Hafler DA. Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells. Journal Of Experimental Medicine 2021, 218: e20200921. PMID: 33651881, PMCID: PMC7933991, DOI: 10.1084/jem.20200921.
- Tran TT, Rane CK, Zito CR, Weiss SA, Jessel S, Lucca L, Lu BY, Oria VO, Adeniran A, Chiang VL, Omay SB, Hafler DA, Kluger HM, Jilaveanu LB. Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells. Cancers 2021, 13: 1049. PMID: 33801444, PMCID: PMC7958624, DOI: 10.3390/cancers13051049.
- Eguren-Santamaria I, Sanmamed MF, Goldberg SB, Kluger HM, Idoate MA, Lu B, Corral J, Schalper KA, Herbst RS, Gil-Bazo I. PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice. Clinical Cancer Research 2020, 26: 4186-4197. PMID: 32354698, DOI: 10.1158/1078-0432.ccr-20-0798.
- Lu B, Gupta R, Stewart T, Kluger H, Jilaveanu L, Schalper K, Goldberg S. Functional profile and clinical significance of major tumor infiltrating lymphocyte subsets in lung cancer-associated brain metastases. Journal Of Clinical Oncology 2019, 37: 2066-2066. DOI: 10.1200/jco.2019.37.15_suppl.2066.
- Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, McLendon RE, Lipp ES, Gururangan S, Grossbach A, French P, Kros JM, van Veelen MC, Rao AAN, Giannini C, Leary S, Jung S, Faria CC, Mora J, Schüller U, Alonso MM, Chan JA, Klekner A, Chambless LB, Hwang EI, Massimino M, Eberhart CG, Karajannis MA, Lu B, Liau LM, Zollo M, Ferrucci V, Carlotti C, Tirapelli DPC, Tabori U, Bouffet E, Ryzhova M, Ellison DW, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Pfister SM, Taylor MD, Aldape K, Pajtler KW, Kool M, Ramaswamy V. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathologica 2018, 136: 227-237. PMID: 30019219, PMCID: PMC6373486, DOI: 10.1007/s00401-018-1888-x.
- Lu B, Gupta R, Ribeiro M, Stewart T, Chiang V, Contessa J, Adeniran A, Kluger H, Jilaveanu L, Schalper K, Goldberg S. PD-L1 expression and tumor-infiltrating lymphocytes in lung cancer brain metastases. Journal Of Clinical Oncology 2018, 36: e24116-e24116. DOI: 10.1200/jco.2018.36.15_suppl.e24116.
- Madhusoodhan P, Lu B, Chen J, Jones C, Meyer J, Roman E, Nardi M, Carroll W, Bhatla T. Splice site mutation in factor X gene manifesting as severe intracranial haemorrhage in neonatal period with a challenging treatment course. Haemophilia 2016, 23: e138-e140. PMID: 27995737, DOI: 10.1111/hae.13138.
- Lu B, Kojima L, Huang M, Friedmann A, Ferry J, Weinstein H. Facial manifestations of Epstein–Barr virus‐related lymphoproliferative disease in childhood acute lymphoblastic leukemia in remission: Two atypical presentations. Pediatric Blood & Cancer 2016, 63: 2042-2045. PMID: 27392033, DOI: 10.1002/pbc.26102.
- Lu B, Thanawala S, Zochowski K, Burke M, Carroll W, Bhatla T. Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples. Leukemia & Lymphoma 2016, 57: 1938-1941. PMID: 26726842, DOI: 10.3109/10428194.2015.1110747.
- Bhatla T, Dandekar S, Lu B, Wang J, Han E, Bitterman D, Jones C, Evensen N, Magid M, Meyer J, Carroll W. Genomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric Patient. Journal Of Pediatric Hematology/Oncology 2016, 38: e21-e25. PMID: 26558807, PMCID: PMC4681625, DOI: 10.1097/mph.0000000000000463.
- Lu B, Kudlowitz D, Gardner L. Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test. Journal Of Blood Medicine 2015, 6: 277-283. PMID: 26640392, PMCID: PMC4657791, DOI: 10.2147/jbm.s90179.
- Henslee A, Yoon D, Lu B, Yu J, Arango A, Marruffo L, Seng L, Anver T, Ather H, Nair M, Piper S, Demian N, Wong M, Kasper F, Mikos A. Characterization of an injectable, degradable polymer for mechanical stabilization of mandibular fractures. Journal Of Biomedical Materials Research Part B Applied Biomaterials 2014, 103: 529-538. PMID: 24934595, DOI: 10.1002/jbm.b.33216.
- Haynes M, Lu B, Winkel A. Ovarian Vein Thrombophlebitis Related to Large Uterine Myoma. Obstetrics And Gynecology 2014, 123: 450-453. PMID: 24413242, DOI: 10.1097/aog.0000000000000091.
- Neumann O, Feronti C, Neumann A, Dong A, Schell K, Lu B, Kim E, Quinn M, Thompson S, Grady N, Nordlander P, Oden M, Halas N. Compact solar autoclave based on steam generation using broadband light-harvesting nanoparticles. Proceedings Of The National Academy Of Sciences Of The United States Of America 2013, 110: 11677-11681. PMID: 23836642, PMCID: PMC3718182, DOI: 10.1073/pnas.1310131110.
- Spiegel G, Dinh C, Gutierrez A, Lukomnik J, Lu B, Shah K, Slough T, Yeh P, Mirabal Y, Gray L, Marton S, Adler M, Schutze G, Wickham H, Oden M, Richards-Kortum R. Design, Evaluation, and Dissemination of a Plastic Syringe Clip to Improve Dosing Accuracy of Liquid Medications. Annals Of Biomedical Engineering 2013, 41: 1860-1868. PMID: 23471817, DOI: 10.1007/s10439-013-0780-z.
- Hároz E, Duque J, Lu B, Nikolaev P, Arepalli S, Hauge R, Doorn S, Kono J. Unique Origin of Colors of Armchair Carbon Nanotubes. Journal Of The American Chemical Society 2012, 134: 4461-4464. PMID: 22239488, DOI: 10.1021/ja209333m.
- Hároz E, Rice W, Lu B, Ghosh S, Hauge R, Weisman R, Doorn S, Kono J. Enrichment of Armchair Carbon Nanotubes via Density Gradient Ultracentrifugation: Raman Spectroscopy Evidence. ACS Nano 2010, 4: 1955-1962. PMID: 20302343, DOI: 10.1021/nn901908n.
- Murakami Y, Lu B, Kazaoui S, Minami N, Okubo T, Maruyama S. Photoluminescence sidebands of carbon nanotubes below the bright singlet excitonic levels. Physical Review B 2009, 79: 195407. DOI: 10.1103/physrevb.79.195407.
- Natoli R, Responte D, Lu B, Athanasiou K. Effects of multiple chondroitinase ABC applications on tissue engineered articular cartilage. Journal Of Orthopaedic Research® 2009, 27: 949-956. PMID: 19123232, PMCID: PMC2819396, DOI: 10.1002/jor.20821.
Departments and Programs